On September 14, 2023 FibroBiologics, a clinical-stage biotechnology company focused on the development of therapeutics and potential cures for chronic diseases using fibroblasts and fibroblast-derived materials, announced today that Pete O’Heeron, Founder/Chief Executive Officer, and Hamid Khoja Ph.D., Chief Scientific Officer, will be giving company presentations at the upcoming Life Science Intelligence (LSI) Europe ’23 Emerging MedTech Summit September 18-22, 2023; and Cell & Gene Meeting on the Mesa October 10-12, 2023.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Details for the upcoming conference presentations are as follows:

LSI Europe ’23 Emerging MedTech Summit (Barcelona, September 18-22)

Presenter: Pete O’Heeron
Date: September 19, 2023
Time: 11:45 a.m. – 11:54 a.m. European Central Time
Location: Gaudi Ballroom

Cell & Gene Meeting on the Mesa (Carlsbad, California. October 10-12)

Presenter: Hamid Khoja, Ph.D.
Date: October 10, 2023
Time: 10:45 a.m. – 11:00 a.m. PST
Location: Rentschler ATMP Ballroom

"Our presence at these conferences illustrates our commitment to staying at the forefront of developing innovative approaches to treatment of chronic diseases, sharing insights, and fostering collaborations with academia and the biotech community that will drive progress and shape the future," said Pete O’Heeron. "These two conferences provide us with the opportunity to showcase the recent strides and achievements of FibroBiologics in advancing our fibroblast cell-based treatments."